Your session is about to expire
← Back to Search
Levothyroxine Sodium for Hypothyroidism
Study Summary
This trial will test a new liquid levothyroxine formula to see if it better manages thyroid function and improves symptoms of hypothyroidism.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What ailments does Levothyroxine Sodium commonly remediate?
"Levothyroxine Sodium has been clinically demonstrated to help manage malignant neoplasms, euthyroid goitre and even obesity."
Is this research attempting to bring on additional participants?
"As per the information presented on clinicaltrials.gov, enrollment for this experiment is open and ongoing. This trial was posted to the site on May 5th 2021 with updates made as recently as May 4th 2021."
What kind of risks does Levothyroxine Sodium pose for those taking it?
"The safety of Levothyroxine Sodium is highly rated with a score of 3 due to its Phase 4 status, which indicates that it has been approved by the relevant authorities."
What is the upper limit for participant enrollment in this trial?
"Confirmed. According to clinicaltrials.gov, the trial which was posted on May 5th 2021 is currently accepting patients. Thirty-four participants must be enrolled from a single medical site and the last edit made to this study occurred on April 4th of this year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- UCLA Center for Human Nutrition: < 24 hours
Average response time
- < 1 Day
Share this study with friends
Copy Link
Messenger